Candida biofilms on implanted biomaterials: a clinically significant problem.

By G. Ramage, José P. Martínez, J. López-Ribot. FEMS Yeast Research, 2006

600 citations recorded by the source corpus.

Subfields: Infectious Diseases, Molecular Biology, Periodontics

View Paper: https://www.semanticscholar.org/paper/e21bba138bd34e789c032cafed0321583937862e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Rosário Oliveira

Citations in the corpus

• Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. (2013, background): “albicans abiotic-surface biofilms consist of two general types of cells: yeast cells and filamentous cells (Finkel & Mitchell, 2011; Ramage et al., 2006).”
• Candida parapsilosis, an Emerging Fungal Pathogen (2008, unknown): “intracardiac prosthetic devices, and prosthetic joints (224).”
• Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. (2012, background): “Initial attachment of Candida to host or/and medical devices is followed by cell division, proliferation and sub- sequent biofilm development (Ramage et al., 2006).”